BioLife Solutions (BLFS) Stock: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$34.95
0.03 (0.09%)
â˛
5d:
-1.63%
30d:
-0.06%
90d:
+31.39%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BLFS is fairly priced but lacks strong directional signals. At -0.7% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BLFS is fairly priced but lacks strong directional signals. At -0.7% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $34.95, which is considered fair relative to its 30-day fair value range of $34.11 to $36.76. The stock's valuation (Forward PE: 105.9) is in line with its historical norms (108.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is currently testing key support at $34.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLFS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is currently testing key support at $34.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BLFS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$34.11 -
$36.76
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding BLFS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 10.5% above Wall St target ($31.29)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$34.11 -
$36.76
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$34.38
Resistance Level
$37.25
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
105.91
Wall Street Target
$31.29
(-10.5%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
-13.9%
Profit Margin
54.4%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
105.9 vs 108.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.7%
(market-implied from PE analysis)
1-Year Target
$34.71
(-1%)
2-Year Target
$34.46
(-1%)
3-Year Target
$34.22
(-2%)
3-Yr Target (if PE normalizes)
(PE: 106â108)
$34.96
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 105.9, Growth: 32.0%)
$80.38
(+130%)
Base:
(SPY PE: 20.2, Growth: 32.0%)
$15.31
(-56%)
Bear:
(PE: 17.1, Growth: 32.0%)
$13.01
(-63%)
đ
Valuation based on Current Earnings
Trailing PE: 34.92 | Current EPS (TTM): $1.00
Bull Case
$19.21
(-45%)
Analyst growth -50.0%, PE expands to 38.4
Base Case
$17.46
(-50%)
Market implied -50.0%, PE stable at 34.9
Bear Case
$23.75
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 105.9 to 108.2
Stabilization Target:
$35.71
(+2.2%)
PE Expansion Potential:
+2.2%
Share & Embed Analysis
Last updated: September 12, 2026 3:22 AM ET
Data refreshes hourly during market hours. Next update: 4:22 AM
Data refreshes hourly during market hours. Next update: 4:22 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
